For professionals in the pharmaceutical research and development sector, identifying and sourcing high-quality chemical intermediates is a cornerstone of success. CAS 179552-74-0, chemically known as N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine, stands out as a critical component in the synthesis of important therapeutic agents, most notably Gefitinib. This compound, typically supplied as a yellow powder with a high assay of ≥98.0%, is essential for creating advanced pharmaceuticals, particularly in the field of oncology.

As a leading manufacturer and supplier, we specialize in providing precisely this CAS-registered intermediate to meet the demanding requirements of the pharmaceutical industry. Our production process is meticulously controlled to ensure consistent quality and purity, allowing our clients to confidently incorporate it into their synthesis routes. The physical properties, including its density and boiling point, are well-characterized, facilitating smooth integration into established manufacturing workflows. We are committed to being a reliable source for this compound, offering competitive pricing and bulk purchase options to support both research-scale needs and large-scale commercial production.

Understanding the supply chain for intermediates like N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine is vital for procurement managers and R&D scientists alike. We aim to demystify this process by emphasizing transparency and reliability. By choosing to buy from our China-based manufacturing operations, you gain access to a supplier with extensive experience in producing pharmaceutical intermediates. This not only ensures product quality but also provides an advantage in terms of cost-effectiveness and supply chain security. Whether you are initiating new drug development projects or scaling up existing manufacturing, our capabilities are designed to meet your needs. Explore the benefits of partnering with a dedicated supplier for CAS 179552-74-0 and enhance your procurement strategy today.